Looking beyond the assay: Comparison of multiplex chromogenic and fluorescent immunohistochemistry for standardized immune oncology profiling in non-small cell lung carcinoma patients (2019)

First Author: Sastre Ana Hidalgo

Attributed to: Immune-checkpoint therapy in non-small cell lung carcinoma:molecular characterisation of tumour microenvironment to improve anti-PD1/PD-L1 drug class. funded by MRC

No abstract provided

Type: Conference/Paper/Proceeding/Abstract

Volume: 7

Parent Publication: JOURNAL FOR IMMUNOTHERAPY OF CANCER

ISSN: 2051-1426